AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Dabigatran Etexilate in Nigeria
3 products registered with NAFDAC — 3 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Hetsolid 110 mg Capsules Capsule | A4-101278 | Hetero Labs Nigeria Limited | active | 29 Apr 2030 |
| Hetsolid 150 mg Capsules Capsule | A4-101279 | Hetero Labs Nigeria Limited | active | 29 Apr 2030 |
| Hetsolid 75 mg Capsules Capsule | A4-101274 | Hetero Labs Nigeria Limited | active | 29 Apr 2030 |
Dabigatran Etexilate — NAFDAC Registration Details
NAFDAC (Nigeria) has 3 registered products containing Dabigatran Etexilate, of which 3 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Dabigatran Etexilate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.